XFRA ISIN CHANGE

Realtime	Geld	Brief	Zeit
	5,240	5,380	13:03
	5,230	5,430	28.11.

Realtime

Geld

Brief

Zeit

5,240

5,380

13:03

5,230

5,430

28.11.

XFRA ISIN CHANGE

Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
SE0007789409 Xbrane Biopharma AB 17.10.2025 SE0026598583 Xbrane Biopharma AB 20.10.2025 Tausch 125:1
GB00B02QND93 PayPoint PLC 17.10.2025 GB00BVMTNR93 PayPoint PLC 20.10.2025 Tausch 13:12
US81727U1051 Senseonics Holdings Inc. 17.10.2025 US81727U3032 Senseonics Holdings Inc. 20.10.2025 Tausch 20:1
US00808Y5050 Aethlon Medical Inc. 17.10.2025 US00808Y6041 Aethlon Medical Inc. 20.10.2025 Tausch 10:1
CA54020J1012 Lodestar Metals Corp. 17.10.2025 CA54020J2002 Lodestar Metals Corp. 20.10.2025 Tausch 2:1

Zeit	Aktuelle Nachrichten
13.11.	Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M
12.11.	Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update	Clinical and research progress continues alongside substantial cost reductions. Conference Call Today at 4:30 p.m. ET SAN DIEGO, Nov. 12, 2025 /PRNewswire/... ► Artikel lesen
12.11.	AETHLON MEDICAL INC - 10-Q, Quarterly Report
11.11.	What to Expect from Aethlon Medical's Earnings
06.11.	AETHLON MEDICAL INC - 8-K, Current Report

Zeit

Aktuelle Nachrichten

13.11.

Aethlon Medical signals expanded Australian oncology enrollment strategy while operating loss narrows to $1.5M

12.11.

Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Clinical and research progress continues alongside substantial cost reductions. Conference Call Today at 4:30 p.m. ET SAN DIEGO, Nov. 12, 2025 /PRNewswire/...
► Artikel lesen

12.11.

AETHLON MEDICAL INC - 10-Q, Quarterly Report

11.11.

What to Expect from Aethlon Medical's Earnings

06.11.

AETHLON MEDICAL INC - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Mi	Lodestar Metals Corp.: Lodestar Metals Closes Third and Final Tranche of Financing	Vancouver, British Columbia--(Newsfile Corp. - November 25, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC: SVTNF) ("Lodestar" or the "Company") announces that it has closed the third and final tranche... ► Artikel lesen
14.11.	Lodestar Metals Corp.: Lodestar Metals Closes Second Tranche of Financing	Vancouver, British Columbia--(Newsfile Corp. - November 13, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTNF) ("Lodestar" or the "Company") announces that it has closed a second tranche... ► Artikel lesen
28.10.	Lodestar Metals Corp (2): Lodestar identifies three Au-Ag anomalies at Goldrun
28.10.	Lodestar Metals Corp.: Lodestar Metals Defines Three Large Gold-Silver Soil Anomalies at Goldrun Property, Nevada	Vancouver, British Columbia--(Newsfile Corp. - October 28, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTND) ("Lodestar" or the "Company"), a junior exploration company unlocking world class... ► Artikel lesen
25.10.	Lodestar Metals Corp (2): Lodestar closes $1.12M first tranche of placement

Zeit

Aktuelle Nachrichten

Lodestar Metals Corp.: Lodestar Metals Closes Third and Final Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC: SVTNF) ("Lodestar" or the "Company") announces that it has closed the third and final tranche...
► Artikel lesen

14.11.

Lodestar Metals Corp.: Lodestar Metals Closes Second Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTNF) ("Lodestar" or the "Company") announces that it has closed a second tranche...
► Artikel lesen

28.10.

Lodestar Metals Corp (2): Lodestar identifies three Au-Ag anomalies at Goldrun

28.10.

Lodestar Metals Corp.: Lodestar Metals Defines Three Large Gold-Silver Soil Anomalies at Goldrun Property, Nevada

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2025) - Lodestar Metals Corp. (TSXV: LSTR) (OTC Pink: SVTND) ("Lodestar" or the "Company"), a junior exploration company unlocking world class...
► Artikel lesen

25.10.

Lodestar Metals Corp (2): Lodestar closes $1.12M first tranche of placement

Zeit	Aktuelle Nachrichten
Mi	PayPoint plc: Director Declaration
Mi	PayPoint plc: Director/PDMR Shareholding
21.11.	Director dealings: Paypoint CEO raises stake
21.11.	PayPoint share price pattern points to a steeper crash to 250p
21.11.	IN BRIEF: PayPoint CEO Nick Wiles buys GBP135,000 in shares

Zeit

Aktuelle Nachrichten

PayPoint plc: Director Declaration

PayPoint plc: Director/PDMR Shareholding

21.11.

Director dealings: Paypoint CEO raises stake

21.11.

PayPoint share price pattern points to a steeper crash to 250p

21.11.

IN BRIEF: PayPoint CEO Nick Wiles buys GBP135,000 in shares

Zeit	Aktuelle Nachrichten
14.11.	Senseonics Holdings, Inc. - 8-A12B, Registration of securities
14.11.	Senseonics Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities
13.11.	XFRA 6L60: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
10.11.	Senseonics announces transfer to Nasdaq
10.11.	Senseonics to transfer stock listing from NYSE American to Nasdaq

Zeit

Aktuelle Nachrichten

14.11.

Senseonics Holdings, Inc. - 8-A12B, Registration of securities

14.11.

Senseonics Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

13.11.

XFRA 6L60: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

10.11.

Senseonics announces transfer to Nasdaq

10.11.

Senseonics to transfer stock listing from NYSE American to Nasdaq

Zeit	Aktuelle Nachrichten
04.11.	Xbrane Biopharma AB: First patient included in Xdivane pivotal clinical trial	Xbrane Biopharma AB (publ) ("Xbrane") (Nasdaq Stockholm: XBRANE) today announce that the first patient has been included in the pivotal clinical trial for Xdivane (nivolumab biosimilar candidate). As... ► Artikel lesen
28.10.	Xbrane Biopharma AB: Siavash Bashiri sells shares to repay loan taken in connection with the 2024 rights issue, but remains a dedicated and long-term employee and shareholder	Xbrane Biopharma AB (publ) ("Xbrane" or "the Company") (Nasdaq Stockholm: XBRANE) announces that Siavash Bashiri of Xbrane's management team have sold shares to pay back a loan that was taken in connection... ► Artikel lesen
24.10.	Xbrane Biopharma AB: Xbrane Biopharma releases Interim Report for January-September 2025	Xbrane Biopharma AB's (publ.) ("Xbrane") Interim Report for January-September 2025, is as of today, available on the Company's website, https://xbrane.com/. FINANCIAL OVERVIEWTHIRD QUARTER 2025*• Revenue... ► Artikel lesen
20.10.	XFRA NEW INSTRUMENTS AVAILABLE ON 20.10.2025	The following instruments on XETRA do have their first trading 20.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 20.10.2025 Aktien 1 AU0000177172 iTech Minerals Ltd. 2... ► Artikel lesen
19.10.	Xbrane Biopharma AB: Xbrane provides Regulatory update on FDA review of its ranibizumab biosimilar candidate	Xbrane Biopharma AB ("Xbrane"), a leading Swedish biosimilar developer, announce that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to the Company's Biologics... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.11.

Xbrane Biopharma AB: First patient included in Xdivane pivotal clinical trial

Xbrane Biopharma AB (publ) ("Xbrane") (Nasdaq Stockholm: XBRANE) today announce that the first patient has been included in the pivotal clinical trial for Xdivane (nivolumab biosimilar candidate). As...
► Artikel lesen

28.10.

Xbrane Biopharma AB: Siavash Bashiri sells shares to repay loan taken in connection with the 2024 rights issue, but remains a dedicated and long-term employee and shareholder

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company") (Nasdaq Stockholm: XBRANE) announces that Siavash Bashiri of Xbrane's management team have sold shares to pay back a loan that was taken in connection...
► Artikel lesen

24.10.

Xbrane Biopharma AB: Xbrane Biopharma releases Interim Report for January-September 2025

Xbrane Biopharma AB's (publ.) ("Xbrane") Interim Report for January-September 2025, is as of today, available on the Company's website, https://xbrane.com/. FINANCIAL OVERVIEWTHIRD QUARTER 2025*• Revenue...
► Artikel lesen

20.10.

XFRA NEW INSTRUMENTS AVAILABLE ON 20.10.2025

The following instruments on XETRA do have their first trading 20.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 20.10.2025 Aktien 1 AU0000177172 iTech Minerals Ltd. 2...
► Artikel lesen

19.10.

Xbrane Biopharma AB: Xbrane provides Regulatory update on FDA review of its ranibizumab biosimilar candidate

Xbrane Biopharma AB ("Xbrane"), a leading Swedish biosimilar developer, announce that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to the Company's Biologics...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AETHLON MEDICAL INC	4,470	+3,71 %
LODESTAR METALS CORP	0,058	+19,18 %
PAYPOINT PLC	5,410	-4,42 %
SENSEONICS HOLDINGS INC	5,090	-4,50 %
XBRANE BIOPHARMA AB	0,766	+3,03 %

Unternehmen / Aktien

Kurs

AETHLON MEDICAL INC

4,470

+3,71 %

LODESTAR METALS CORP

0,058

+19,18 %

PAYPOINT PLC

5,410

-4,42 %

SENSEONICS HOLDINGS INC